We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current NGM market cap is 70.99M. The company's latest EPS is USD -1.9666 and P/E is -0.43.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 7.91M | 18.18M | 2.25M | 1.42M | 582k |
| Operating Income | -48.3M | -38.3M | -50.19M | -40.58M | -31.03M |
| Net Income | -47.26M | -36.44M | -47.65M | -38.26M | -28.8M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 108.67M | 103.54M | 87.37M | 77.88M | 55.33M |
| Operating Income | -4.31M | -49.34M | -103.83M | -120.7M | -166.25M |
| Net Income | -493k | -42.8M | -102.49M | -120.34M | -162.67M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 335.87M | 307.4M | 258.84M | 220.54M | 192.15M |
| Total Liabilities | 49.98M | 47.84M | 37.9M | 28.42M | 22.35M |
| Total Equity | 285.89M | 259.56M | 220.93M | 192.12M | 169.81M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 246.09M | 380.4M | 329.04M | 402.39M | 307.4M |
| Total Liabilities | 59.41M | 49.68M | 49M | 66.74M | 47.84M |
| Total Equity | -108.2M | 330.72M | 280.04M | 335.65M | 259.56M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -114.04M | -144.44M | -41.83M | -82.08M | -109.24M |
| Investing | 12.63M | 14.32M | 35.64M | 60.23M | 87.1M |
| Financing | 53.51M | 54.23M | 279k | 1.66M | 1.66M |
| Year End December 30 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -7.6M | -41.17M | -83.5M | -73.23M | -144.44M |
| Investing | 38.73M | 48.72M | -51M | -71.65M | 14.32M |
| Financing | 198k | 180.75M | 35.54M | 149.66M | 54.23M |
| Market Cap | 70.99M |
| Price to Earnings Ratio | -0.43 |
| Price to Sales Ratio | 1.27 |
| Price to Cash Ratio | 0.96 |
| Price to Book Ratio | 0.27 |
| Dividend Yield | - |
| Shares Outstanding | 82.72M |
| Average Volume (1 week) | 181.7k |
| Average Volume (1 Month) | 436.36k |
| 52 Week Change | -84.97% |
| 52 Week High | 5.82 |
| 52 Week Low | 0.6002 |
| Spread (Intraday) | 0.07 (8.1%) |
| Company Name | NGM Biopharmaceuticals Inc |
| Address |
850 new burton road dover, delaware 19904 |
| Website | https://www.ngmbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
